Truist lowered the firm’s price target on Amphenol to $97 from $101 and keeps a Buy rating on the shares after its Q3 results. The company beat Q3 estimates but only guided inline with consensus, hurt by weakening industrial demand, the analyst tells investors in a research note. Truist still recommends that investors buy the stock for long-term compound growth and near-term superior execution through an otherwise volatile semi/components cycle.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on APH: